睡眠障碍认知行为治疗对照研究

目的评价认知行为治疗对睡眠障碍的I艋床疗效。方法将60例睡眠障碍患者随机分为两组，每组30例，研究组给予认知行为治疗，对照组口服酒石酸唑吡坦治疗，观察4周。于治疗前及治疗1周、2周、4周末采用汉密顿焦虑量表、临床总体疗效评定量表评定临床疗效。结果治疗后两组汉密顿焦虑量表、临床总体疗效评定量表评分均呈持续性下降（P〈0．05或0．01）；同期两组间比较均无显著性差异（P〉0．05），但研究组治疗第4周末汉密顿焦虑量表总分较对照组下降显著；随着治疗时问的延续临床痊愈率、总有效率均呈持续性升高，治疗4周末研究组总有效率为76．67％，对照组为70．00％，两组无显著性差异（P〉0．05）。结论认知行为治疗与酒石酸唑吡坦治疗睡眠障碍疗效均显著，但认知行为治疗的远期疗效更为显著，优于酒石酸唑吡坦治疗。

A control study of cognitive behavioral therapy for sleep disorders

Objective To assess the clinical effect of cognitive behavioral therapy（CBT） for sleep disorders. Methods Sixty patients with sleep disorders were randomly divided into two groups of 30 ones each, research group received CBT and control group took orally zolpidem tartrate for 4 weeks. Clinical efficacies were assessed with the Hamilton Anxiety Scale（HAMA） and the Clinical Global Impression（CGI） before treatment and at the end of the 1st , 2na and 4th week. Results After treatment, the HAMA and CGI scores of both groups lowered continously（P〈0.05 or 0. 01） ; there were no significantly differences between 2 groups（P〉0.05） ,but at the end of the 4th week, total scores of the HAMA in the research lowered more significantly than in the control group; with treatment, clinical recovery and total effective rates advanced continously, at the end of the 4th week the total effective rates were respectively 76.67% in the research and 70.00% in the control group, which showed no significant difference（P〉0.05）. Conclusion Both the CBT and zolpidem tartrate have evidents effects in the treatment of sleep disorders, but the long-term effect of the CBT is more significant.